FDA warns Glaxo on cancer drug promotions
GlaxoSmithKline PLC sent misleading letters to health professionalstouting its breast cancer drug Tykerb, U.S. health officials saidin a letter released on Monday.
More... |
All times are GMT -7. The time now is 12:20 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021